Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 2
2002 5
2003 7
2004 2
2005 2
2006 1
2007 4
2008 8
2009 6
2010 6
2011 9
2012 10
2013 6
2014 6
2015 14
2016 12
2017 8
2018 8
2019 13
2020 7
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

131 results
Results by year
Filters applied: . Clear all
Page 1
Management of patients with multidrug-resistant tuberculosis.
Lange C, Aarnoutse RE, Alffenaar JWC, Bothamley G, Brinkmann F, Costa J, Chesov D, van Crevel R, Dedicoat M, Dominguez J, Duarte R, Grobbel HP, Günther G, Guglielmetti L, Heyckendorf J, Kay AW, Kirakosyan O, Kirk O, Koczulla RA, Kudriashov GG, Kuksa L, van Leth F, Magis-Escurra C, Mandalakas AM, Molina-Moya B, Peloquin CA, Reimann M, Rumetshofer R, Schaaf HS, Schön T, Tiberi S, Valda J, Yablonskii PK, Dheda K. Lange C, et al. Among authors: aarnoutse re. Int J Tuberc Lung Dis. 2019 Jun 1;23(6):645-662. doi: 10.5588/ijtld.18.0622. Int J Tuberc Lung Dis. 2019. PMID: 31315696 Review.
Antituberculosis drug-induced hepatotoxicity: concise up-to-date review.
Tostmann A, Boeree MJ, Aarnoutse RE, de Lange WC, van der Ven AJ, Dekhuijzen R. Tostmann A, et al. Among authors: aarnoutse re. J Gastroenterol Hepatol. 2008 Feb;23(2):192-202. doi: 10.1111/j.1440-1746.2007.05207.x. Epub 2007 Nov 6. J Gastroenterol Hepatol. 2008. PMID: 17995946 Review.
A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria.
Ruth MM, Sangen JJN, Remmers K, Pennings LJ, Svensson E, Aarnoutse RE, Zweijpfenning SMH, Hoefsloot W, Kuipers S, Magis-Escurra C, Wertheim HFL, van Ingen J. Ruth MM, et al. Among authors: aarnoutse re. J Antimicrob Chemother. 2019 Apr 1;74(4):935-943. doi: 10.1093/jac/dky526. J Antimicrob Chemother. 2019. PMID: 30649327
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Boeree MJ, Diacon AH, Dawson R, Narunsky K, du Bois J, Venter A, Phillips PP, Gillespie SH, McHugh TD, Hoelscher M, Heinrich N, Rehal S, van Soolingen D, van Ingen J, Magis-Escurra C, Burger D, Plemper van Balen G, Aarnoutse RE; PanACEA Consortium. Boeree MJ, et al. Among authors: aarnoutse re. Am J Respir Crit Care Med. 2015 May 1;191(9):1058-65. doi: 10.1164/rccm.201407-1264OC. Am J Respir Crit Care Med. 2015. PMID: 25654354 Clinical Trial.
Rifampicin Transport by OATP1B1 Variants.
Litjens CHC, van den Heuvel JJMW, Russel FGM, Aarnoutse RE, Te Brake LHM, Koenderink JB. Litjens CHC, et al. Among authors: aarnoutse re. Antimicrob Agents Chemother. 2020 Sep 21;64(10):e00955-20. doi: 10.1128/AAC.00955-20. Print 2020 Sep 21. Antimicrob Agents Chemother. 2020. PMID: 32690641 Free PMC article.
[Therapeutic drug monitoring of antimicrobials].
Mouton JW, Aarnoutse RE. Mouton JW, et al. Among authors: aarnoutse re. Ned Tijdschr Geneeskd. 2014;158:A7520. Ned Tijdschr Geneeskd. 2014. PMID: 24988163 Review. Dutch.
131 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page